Suppr超能文献

反射性晕厥治疗的新选择。

Novel Therapeutic Options in the Management of Reflex Syncope.

机构信息

Department of Cardiology, University of Pharmacy and Medicine Tirgu Mures, Târgu Mureş, Romania.

Cardiology Department, CHU La Timone, Marseille, France.

出版信息

Am J Ther. 2019 Mar/Apr;26(2):e268-e275. doi: 10.1097/MJT.0000000000000923.

Abstract

BACKGROUND

Syncope is a symptom associated with a wide range of pathological conditions, ranging from benign to life threatening. The most frequent is the reflex syncope that may be challenging to treat because of the complex and partially unknown pathophysiological mechanism that has to be addressed by the chosen therapy.

AREAS OF UNCERTAINTY

Head-up tilt testing is so far the only clinical test able to reproduce reflex syncope, but its diagnostic yield has been recently redefined. A new mechanism such as adenosine-sensitive syncope and idiopathic atrioventricular block have been recently described, and the appropriate therapy is not yet established. There is uncertainty on the efficacy of theophylline and on the use of cardiac pacing in these patients.

DATA SOURCES

Clinical trial published data and position paper from the main expert groups on fludrocortisone, midodrine, etilefrine, beta-blockers, and cardiac pacing as useful therapies for patients affected by reflex syncope.

THERAPEUTIC ADVANCES

Theophylline proved in observational trials to be efficient in preventing reflex syncope recurrences in patients with documented spontaneous paroxysmal conduction disorders comparable to cardiac pacing in a subgroup of patients. Reboxetine and sibutramine may elicit a significant pressor and tachycardic effect able to delay the onset of symptoms during head-up tilt testing. Droxidopa has short-term effects on improving the symptoms because of orthostatic hypotension. Cardiac pacing is effective in preventing reflex syncope recurrences with best results when the indication for pacemaker implantation was based on the documentation of bradycardia or asystole during the spontaneous event by a cardiac monitor. External compression using elastic bandage or compressive stockings is able to prevent the decrease in blood pressure in patients with orthostatic hypotension.

CONCLUSIONS

The optimal management of the complex diagnostic and therapeutic options can be achieved following a standardized and evidence-based approach to the patient with syncope.

摘要

背景

晕厥是一种与广泛的病理状况相关的症状,从良性到危及生命不等。最常见的是反射性晕厥,由于治疗所涉及的复杂且部分未知的病理生理机制,可能难以治疗。

不确定性领域

迄今为止,头高位倾斜试验是唯一能够重现反射性晕厥的临床检查,但最近对其诊断效果进行了重新定义。最近描述了腺苷敏感晕厥和特发性房室传导阻滞等新机制,适当的治疗方法尚未确定。茶碱的疗效和这些患者心脏起搏的使用存在不确定性。

数据来源

关于氟氢可的松、米多君、依替福林、β受体阻滞剂和心脏起搏的临床研究发表数据和主要专家组的立场文件,这些均为反射性晕厥患者的有用治疗方法。

治疗进展

茶碱在观察性试验中被证明可有效预防有记录的自发性阵发性传导障碍患者的反射性晕厥复发,在某些患者中与心脏起搏的效果相当。瑞波西汀和西布曲明可能会引起显著的升压和心动过速作用,能够在头高位倾斜试验中延迟症状的发作。屈昔多巴对改善直立性低血压引起的症状有短期效果。心脏起搏可有效预防反射性晕厥复发,当起搏器植入的指征基于心脏监测器记录到自发性事件中的心动过缓或停搏时,效果最佳。弹性绷带或压缩袜等外部压迫可防止直立性低血压患者血压下降。

结论

通过对晕厥患者进行标准化和基于证据的方法,可以实现对复杂诊断和治疗选择的最佳管理。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验